Krónikus mieloid leukémia (CML): vizsgálatok itt: Szaúd-Arábia
2 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 4. fázisBefejeződöttAsciminib Roll-over Study
- Where
- Riyadh
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - No phaseTaking peopleRWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)
- Where
- Dammam, Jeddah, Riyadh
- Életkor
- 18 év to 99 év
- People
- 40
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06684964